
US Tariffs Fatal for European Pharma
Trump's tariff policy is a considerable burden and a break with previous practice.
Trump's tariff policy is a considerable burden and a break with previous practice.
The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.